The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 28, 2026
Snapshot (as of Sep 28, 2026): Bayer AG (BAYRY) pays a $0.03 annual dividend, yielding 0.22% at $14.32/share. Next ex-dividend date 2026-04-28. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.22%
Annual Dividend: $0.03 per share
Payout Ratio: -7.5%
Ex-Dividend Date: 2026-04-28
Dividend Frequency: annually
Sector: Healthcare
Years of Dividend History: 32
Bayer AG is a global life sciences company spanning pharmaceuticals, consumer health, and crop science, with operations ranging from cardiology drugs to agricultural pest control. The Bayer AG dividend currently yields 0.23%, with a trailing annual dividend rate of $0.0275 per share paid annually. The next ex-dividend date is April 28, 2026. With a beta of 0.833, BAYRY stock moves less than the broader market, which appeals to investors who prioritize lower volatility over high income.
Bayer AG pays out -7.5% of earnings as dividends, a payout ratio classified as conservative (below 40%). A negative payout ratio reflects a period of reported losses rather than dividend strain, and the $0.0275 annual rate is low enough that Bayer AG dividend safety is not currently threatened by the payout level alone. The more meaningful pressure point is earnings recovery: the company's ability to sustain even this modest payment depends on profitability returning across its pharmaceuticals, consumer health, and crop science segments.
Bayer AG dividend history shows a CAGR of -18.9% per year from 2007 to 2025. Per-share payments fell from $1.3592 to $0.0311 over that window (with 2026 a partial year, the most recent complete figure is $0.0311 for 2025). The largest annual increase in the window was 54.2% in 2008, but the overall trend has been sharply negative, and the data contains at least one year-over-year decline exceeding 5%.
| Period | CAGR | From | To |
|---|---|---|---|
| 10-Year | -25.8% | $0.62 (2015) | $0.03 (2025) |
BAYRY stock fits dividend investors who want exposure to a diversified life sciences business and can accept a very low current income stream. The yield sits at low (below 2%), specifically 0.23%, far below the 5-year average of 2.61%, which shows how much ground the dividend has lost in recent years. The payout ratio is conservative, so the current payment is not under mechanical pressure, but the long-term CAGR of -18.9% makes this a poor fit for anyone seeking income growth. The trade-off is clear: low volatility and a broad business spanning prescription drugs, over-the-counter products, and crop science, in exchange for a dividend that has shrunk dramatically over time.
| Payment Date | Amount per Share |
|---|---|
| 2026-04-28 | $0.0321 |
| 2025-04-29 | $0.0311 |
| 2024-04-29 | $0.0294 |
| 2023-05-02 | $0.6602 |
| 2022-05-02 | $0.5258 |
| 2021-04-28 | $0.6041 |
| 2020-04-29 | $0.7626 |
| 2019-04-29 | $0.7823 |
| 2018-06-22 | $0.4162 |
| 2018-05-25 | $0.8131 |
| Year | Total Dividends |
|---|---|
| 2026 | $0.0321 |
| 2025 | $0.0311 |
| 2024 | $0.0294 |
| 2023 | $0.6602 |
| 2022 | $0.5258 |
Project income from BAYRY with the BAYRY dividend calculator or track your full portfolio with the dividend tracker.